Log in

NASDAQ:HOTHHoth Therapeutics Stock Price, Forecast & News

$2.84
-0.10 (-3.40 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.82
Now: $2.84
$2.94
50-Day Range
$2.80
MA: $3.39
$4.08
52-Week Range
$2.60
Now: $2.84
$9.07
Volume554,400 shs
Average Volume319,640 shs
Market Capitalization$32.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.11
Hoth Therapeutics, Inc., a development stage biopharmaceutical company, focuses on developing targeted therapeutics for atopic dermatitis. It intends to use the BioLexa Platform to develop 2 topical cream products that treat eczema and reduces post-procedure infections for patients undergoing aesthetic dermatology procedures. The company was incorporated in 2017 and is based in New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HOTH
CUSIPN/A
CIKN/A
Phone646-756-2997

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.42 per share

Profitability

Net Income$-7,700,000.00

Miscellaneous

Employees2
Market Cap$32.95 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive HOTH News and Ratings via Email

Sign-up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter.

Hoth Therapeutics (NASDAQ:HOTH) Frequently Asked Questions

How has Hoth Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Hoth Therapeutics' stock was trading at $3.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HOTH shares have decreased by 26.0% and is now trading at $2.84. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Hoth Therapeutics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hoth Therapeutics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Hoth Therapeutics.

When is Hoth Therapeutics' next earnings date?

Hoth Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Hoth Therapeutics.

How were Hoth Therapeutics' earnings last quarter?

Hoth Therapeutics Inc (NASDAQ:HOTH) posted its earnings results on Wednesday, May, 13th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.01. View Hoth Therapeutics' earnings history.

What price target have analysts set for HOTH?

1 equities research analysts have issued twelve-month price objectives for Hoth Therapeutics' shares. Their forecasts range from $10.00 to $10.00. On average, they expect Hoth Therapeutics' stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 252.1% from the stock's current price. View analysts' price targets for Hoth Therapeutics.

Has Hoth Therapeutics been receiving favorable news coverage?

Press coverage about HOTH stock has been trending negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Hoth Therapeutics earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutHoth Therapeutics.

Are investors shorting Hoth Therapeutics?

Hoth Therapeutics saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 13,000 shares, a decrease of 7.8% from the April 30th total of 14,100 shares. Based on an average trading volume of 265,400 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.2% of the shares of the company are sold short. View Hoth Therapeutics' Current Options Chain.

Who are some of Hoth Therapeutics' key competitors?

What other stocks do shareholders of Hoth Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hoth Therapeutics investors own include Gilead Sciences (GILD), Citius Pharmaceuticals (CTXR), Inovio Pharmaceuticals (INO), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Pfizer (PFE), Novavax (NVAX), Opko Health (OPK), Verizon Communications (VZ) and AbbVie (ABBV).

Who are Hoth Therapeutics' key executives?

Hoth Therapeutics' management team includes the following people:
  • Mr. Robb Knie, Pres, CEO & Director (Age 50)
  • Mr. David S. Briones, Chief Financial Officer (Age 43)
  • Ms. Jane H. Behrmann, VP of Operations (Age 34)

When did Hoth Therapeutics IPO?

(HOTH) raised $8 million in an initial public offering (IPO) on Friday, February 15th 2019. The company issued 1,300,000 shares at $5.50-$6.50 per share. Laidlaw & Company (UK) Ltd. served as the underwriter for the IPO.

What is Hoth Therapeutics' stock symbol?

Hoth Therapeutics trades on the NASDAQ under the ticker symbol "HOTH."

How do I buy shares of Hoth Therapeutics?

Shares of HOTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hoth Therapeutics' stock price today?

One share of HOTH stock can currently be purchased for approximately $2.84.

How big of a company is Hoth Therapeutics?

Hoth Therapeutics has a market capitalization of $32.95 million. Hoth Therapeutics employs 2 workers across the globe.

What is Hoth Therapeutics' official website?

The official website for Hoth Therapeutics is www.hoththerapeutics.com.

How can I contact Hoth Therapeutics?

Hoth Therapeutics' mailing address is 1 Rockefeller Plaza Suite 1039, New York NY, 10020. The company can be reached via phone at 646-756-2997 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.